Close Menu

NEW YORK (GenomeWeb) – Personalized Wellness firm Arivale has suspended its direct-to-consumer business, stating on its website that the genetic, microbiome, and other lab tests involved in its coaching and monitoring service remain too costly for its business model to succeed at this time.

The timing is abrupt, considering that the company was anticipating a new study describing results in 2,500 participants, which it said has now been accepted for publication in Scientific Reports.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.